Filing Flows › AtriCure (ATRC) › Q3 2026
AtriCure (ATRC) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 4, 2026
AtriCure (ATRC) reported revenue of $154M for the third quarter 2026 (Q3 2026), +15% from a year earlier and +0.6% from the quarter before. Operating margin was 2.8%, net earnings $4.1M (2.6% of revenue).
AtriCure, Q3 2026: revenue $154M (+15% year over year), operating margin 2.8%, net earnings $4.1M, operating cash flow $30.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $154M | +0.6% | +15% |
| Gross profit | $119M | +0.6% | +18% |
| Operating profit | $4.4M | -55% | 21× |
| Net earnings | $4.1M | -55% | — |
| Operating cash flow | $30.3M | +37% | +13% |
| Free cash flow | $23.9M | +30% | -0.7% |
What changed
Revenue was $154.4M in Q3 2026, up 15% year over year and up 1% from the previous quarter.
Gross margin was 77.3%, up 1.8 points from Q3 2025. Operating profit was $4.4M, a 2.8% margin (up 2.7 points year over year). Of the extra revenue versus Q3 2025, 21% reached operating profit, above the 0% margin then. Operating expenses grew 14% against revenue growth of 15%. The fastest-growing cost line was Research & development (+40%). Net earnings were $4.1M. The effective tax rate was -1.2%.
Operating cash flow was $30.3M (up 13% year over year), 746% of net earnings. Non-cash charges added back $5.5M of depreciation and amortization and $12.5M of share-based compensation. Working capital and other items added $8.3M. Capital expenditures of $6.4M left free cash flow of $23.9M.
Questions
What was AtriCure's revenue in the third quarter 2026?
AtriCure (ATRC) reported revenue of $154M for the third quarter 2026 (Q3 2026), +15% from a year earlier and +0.6% from the quarter before.
Was AtriCure profitable in the third quarter 2026?
Operating profit was $4.4M (2.8% of revenue) and net earnings $4.1M.
Source: AtriCure 10-Q on SEC EDGAR.